Delivery Order SPE2DB22D1017-SPE2DB25FG0VC

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 20 mg capsules. The contract has a firm-fixed price and a total ceiling value of $2,696.67, with an ultimate completion date of April 23, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 20 mg capsules. The contract has a firm fixed price of $4,403.54 and a completion date of April 14, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,154.10, is for the delivery of 4,567,925,429 units of the medication Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of April 16, 2025 and was awarded on April 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 40 mg capsules. The contract has a ceiling value of $18,940.52 and an ultimate completion date of September 11, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999, and the Department of Justice Federal Bureau of...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,139.28, is for the delivery of Carvedilol ER 20 mg capsules. The contract has an ultimate completion date of March 5, 2025 and is a firm fixed-price contract. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Carvedilol ER 20 mg capsules. The $35,951.34 firm-fixed-price contract has an ultimate completion date of August 14, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows the agency to efficiently procure a comprehensive range of...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,727.22, is for the delivery of Carvedilol ER 20 mg capsules to support federal healthcare programs. The order has an ultimate completion date of April 13, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 20 mg capsules. The contract has a firm fixed price of $14,476.35 and a completion date of February 10, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of Carvedilol ER 20 mg capsules. The contract has a ceiling value of $1,200.47 and an ultimate completion date of April 3, 2024. This order is placed against an Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 through December 31, 2025. The IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Carvedilol ER 10 mg capsules, a generic cardiovascular medication. The contract has a firm fixed price and a ceiling value of $5,997.90, with a performance period through April 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FG0VC
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Carvedilol ER 20 mg capsules. The total ceiling value of the contract is $1,577.48, with an ultimate completion date of April 23, 2025. The contract is not set aside and was awarded on April 22, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is part of the company's ongoing support of federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/22/25, 10:04 AM